• News & Media
  • Contact
  • Home
  • About Us
    • Our Commitment
    • The Story Behind Our Name
    • Leadership
    • Board of Directors
  • Our Approach
    • Precision Medicines
    • Overcoming Resistance
    • Novel Biomarkers
  • Pipeline
    • Ziftomenib
    • Tipifarnib
    • KO-2806
    • Posters and Presentations
    • Scientific Manuscripts
    • Access To Investigational Drugs Outside a Clinical Study
  • Clinical Trials
    • Overview of Clinical Trials
    • Ziftomenib Clinical Trials
    • KOMET-001 – AML
    • KOMET-007 – AML
    • KOMET-008 – AML
    • Tipifarnib Clinical Trials
    • KURRENT-HN – HNSCC
    • KO-2806 Clinical Trials
    • FIT-001 – Solid Tumors
  • Patients & Caregivers
    • Acute Leukemias
    • Head & Neck Cancer
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Analyst Coverage
    • FAQs
    • Contact
  • Careers
    • Values
    • Life At Kura
    • Benefits
    • Open Positions
  • News & Media
  • Contact
  • Menu Menu

AML World Awareness Day and Kura’s Commitment

April 17, 2025/in 2025, Kura Kommentary, Type, Year
Read more
https://kuraoncology.com/wp-content/uploads/World_AML.jpg 366 670 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2025-04-17 11:00:372025-04-24 16:36:12AML World Awareness Day and Kura’s Commitment

From Lab to Clinic: The Origin and Journey of Menin Inhibitors for AML Research

November 15, 2024/in 2024, Kura Kommentary, Perspectives, Type, Year
Read more
https://kuraoncology.com/wp-content/uploads/FromLabtoClinic.jpg 450 800 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2024-11-15 15:25:492024-11-19 10:25:58From Lab to Clinic: The Origin and Journey of Menin Inhibitors for AML Research

Breakthrough Therapy Designation Granted for Ziftomenib in R/R NPM1-Mutant AML

August 1, 2024/in 2024, Kura Kommentary, Perspectives, Year
Read more
https://kuraoncology.com/wp-content/uploads/Breakthrough_Therapy.jpg 450 800 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2024-08-01 16:00:302024-11-18 11:49:19Breakthrough Therapy Designation Granted for Ziftomenib in R/R NPM1-Mutant AML

Accelerating Bio Innovation 2024

August 1, 2024/in 2024, Kura Kommentary, link_off, Perspectives, Year
Read more
https://kuraoncology.com/wp-content/uploads/Accelerating_Bio_Innocation.jpg 450 800 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2024-08-01 12:00:212024-08-02 12:51:02Accelerating Bio Innovation 2024

AML World Awareness Day 2024

June 27, 2024/in 2024, Kura Kommentary, Perspectives, Year
Read more
https://kuraoncology.com/wp-content/uploads/AML_WorldAwarenessDay.jpg 447 800 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2024-06-27 15:00:562024-06-28 10:33:04AML World Awareness Day 2024

Kura CEO Troy Wilson on the Inflation Reduction Act

June 27, 2024/in 2024, Kura Kommentary, Perspectives, Year
Read more
https://kuraoncology.com/wp-content/uploads/Inflation_Thumbnail.jpg 449 800 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2024-06-27 12:00:342024-08-15 11:31:24Kura CEO Troy Wilson on the Inflation Reduction Act

CEO Troy Wilson On Giving Back: Empowering Young Minds to Explore Life Sciences

September 7, 2023/in 2023, Kura Kommentary, Perspectives, Type, Year
Read more
https://kuraoncology.com/wp-content/uploads/LinkedIn-article-banner.png 834 1444 David Anderson /wp-content/uploads/kura-logo-registered-blue.svg David Anderson2023-09-07 16:00:112023-09-18 16:46:28CEO Troy Wilson On Giving Back: Empowering Young Minds to Explore Life Sciences

World Medical Innovation Forum Panel on The Innovation Gap: The Promise of Precision Oncology for Liquid Tumors

June 13, 2023/in 2023, Kura Kommentary, Perspectives, Type, Year
Read more
https://kuraoncology.com/wp-content/uploads/World-Medical-Panel-Image.jpg 456 836 David Anderson /wp-content/uploads/kura-logo-registered-blue.svg David Anderson2023-06-13 08:00:522023-08-23 14:34:01World Medical Innovation Forum Panel on The Innovation Gap: The Promise of Precision Oncology for Liquid Tumors

What pharma can teach biotech about the life cycle management of a drug

May 18, 2023/in 2023, Kura Kommentary, Perspectives, Type, Year
Read more
https://kuraoncology.com/wp-content/uploads/Pharma-Can-Teach-Image.jpg 456 836 David Anderson /wp-content/uploads/kura-logo-registered-blue.svg David Anderson2023-05-18 08:00:212023-08-24 17:30:17What pharma can teach biotech about the life cycle management of a drug

Kura Oncology 2022 Annual Report

April 20, 2023/in 2022, Kura Kommentary, Perspectives, Type, Year
Read more
https://kuraoncology.com/wp-content/uploads/Annual-Report-img.jpg 456 836 David Anderson /wp-content/uploads/kura-logo-registered-blue.svg David Anderson2023-04-20 08:00:412023-08-23 14:32:33Kura Oncology 2022 Annual Report
Page 1 of 212
  • About Us
  • Our Commitment
  • The Story Behind Our Name
  • Leadership
  • Board of Directors
  • Our Approach
  • Precision Medicines
  • Overcoming Resistance
  • Novel Biomarkers
  • Pipeline
  • Ziftomenib
  • Tipifarnib
  • KO-2806
  • Posters and Presentations
  • Scientific Manuscripts
  • Access to Investigational Drugs Outside a Clinical Study
  • Clinical Trials
  • Overview of Clinical Trials
  • Ziftomenib Clinical Trials
  • KOMET-001 – AML
  • KOMET-007 – AML
  • KOMET-008 – AML
  • Tipifarnib Clinical Trials
  • KURRENT-HN – HNSCC
  • KO-2806 Clinical Trials
  • FIT-001 – Solid Tumors
  • Patients & Caregivers
  • Acute Leukemias
  • Head & Neck Cancer
  • Investors
  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financial Information
  • Analyst Coverage
  • FAQs
  • Contact
  • Careers
  • Values
  • Life at Kura
  • Benefits
  • Open Positions
  • News & Media
  • Press Releases
  • News & Perspectives
  • Expert Perspectives
  • Media Resources
  • Contact

Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

Kura Oncology, Inc.
5510 Morehouse Drive, Suite 110
San Diego, California 92121

© 2025 Kura Oncology, Inc. All Rights Reserved | Terms of Use | Privacy Policy

Scroll to top Scroll to top Scroll to top